Skip to main content
    T

    Takeda Pharmaceutical Co Ltd ADR (TAK)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE

    $21.64
    +0.05 (+0.25%)

    Market Cap: $68.98B

    Last updated: Nov 17, 2026 at 4:37 PM ET

    Takeda Pharmaceutical Co Ltd ADR (TAK) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Takeda Pharmaceutical Co Ltd ADR (TAK) has a market cap of $68.98B. It earned JPY 386.37B on revenue of JPY 4.73T over the last 12 months.

    Total Valuation

    Market Cap$68.98B
    Latest price (Nov 17, 2026)$21.64

    Key Dates

    The last ex-dividend date was Mar 31, 2026.

    Last Earnings DateOct 29, 2026
    Last Ex-Dividend DateMar 31, 2026
    Last Payment DateJul 6, 2026
    Fiscal Year EndMarch

    Share Statistics

    The share count held steady in the quarter ended Sep 30, 2026 and shrank 0.17% a year over 2 years.

    Shares Outstanding3.21B
    Shares Change (YoY)+1.73%
    Shares Change (QoQ)0.00%
    Share Count Growth (2Y CAGR)-0.17%

    Valuation Ratios

    Sales and book value multiples are 2.3x and 1.5x. Its year-end P/S ranged from 1.4x to 2.8x from 2016 to 2025.

    P/S Ratio2.3x
    P/B Ratio1.5x
    P/FCF Ratio24.5x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 11.5x EBITDA and 33.9x free cash flow.

    EV / EBITDA11.5x
    EV / FCF33.9x

    Price Statistics

    The stock is up 53.99% over 52 weeks and trades 10.80% above its 50-day average.

    Beta (1Y)0.04
    52-Week Change+53.99%
    1-Month Change+10.38%
    3-Month Change+18.02%
    6-Month Change+30.55%
    5-Year Change+49.14%
    10-Year Change-6.86%
    Total Return (1Y)+56.18%
    Total Return (3Y CAGR)+19.84%
    Total Return (5Y CAGR)+13.23%
    Return vs SPY (1Y)+44.84%
    Max Drawdown (1Y)-19.93%
    Max Drawdown (3Y)-19.93%
    Sharpe Ratio (1Y)2.10
    Correlation with SPY (1Y)0.03
    50-Day Average$19.53
    200-Day Average$17.76
    52-Week Range$13.48 to $21.86
    RSI (14 Days)72.5
    Average Volume (20 Days)3.03M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.15x current liabilities, and total debt is 0.62x shareholder equity.

    Current Ratio1.15x
    Quick Ratio0.60x
    Debt / Equity0.62x
    Debt / EBITDA3.49x
    Interest Coverage2.34x

    Returns and Efficiency

    Return on invested capital is 5.58% over the last 12 months, against a 5-year average of 3.13%.

    Return on Equity (ROE)5.17%
    Return on Assets (ROA)2.51%
    Return on Invested Capital (ROIC)5.58%
    Return on Capital Employed (ROCE)5.52%
    ROE (5Y Average)2.12%
    ROA (5Y Average)0.95%
    ROIC (5Y Average)3.13%
    Asset Turnover0.32x
    Inventory Turnover1.34x
    Receivables Turnover5.11x
    Cash Conversion Cycle255 days

    Taxes

    Income tax took 3.71% of pretax income over the last 12 months.

    Income Tax (TTM)JPY 14.91B
    Effective Tax Rate3.71%

    Scores

    TAK has an Altman Z-Score of 1.40, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score1.40
    Altman Z ZoneDistress
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of JPY 4.73T over the last 12 months is up 7.20% from the 12 months before.

    RevenueJPY 4.73T
    Revenue Growth (YoY)+7.20%
    Gross ProfitJPY 2.81T
    Operating IncomeJPY 648.34B
    Pretax IncomeJPY 401.53B
    Net IncomeJPY 386.37B
    EBITDAJPY 1.32T
    EBITJPY 699.06B

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 48.59% of the JPY 15.27T in total assets.

    Working CapitalJPY 393.61B
    Shareholder EquityJPY 7.42T
    Tangible Book ValueJPY -1.49T
    Total AssetsJPY 15.27T
    Total LiabilitiesJPY 7.85T

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After JPY 385.11B of capital spending, operating cash flow left JPY 447.47B of free cash flow.

    Operating Cash FlowJPY 832.59B
    Capital ExpendituresJPY 385.11B
    Free Cash FlowJPY 447.47B
    Depreciation and AmortizationJPY 681.46B
    Dividends PaidJPY 315.52B

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 13.69%, against a 5-year average of 7.55%.

    Gross Margin59.40%
    Operating Margin13.69%
    Pretax Margin8.48%
    Net Margin8.16%
    EBITDA Margin27.96%
    EBIT Margin14.76%
    FCF Margin9.45%
    Gross Margin (5Y Average)67.03%
    Operating Margin (5Y Average)7.55%
    Net Margin (5Y Average)3.33%

    Growth

    Revenue grew 3.81% a year over 3 years.

    Revenue Growth (3Y CAGR)+3.81%
    Revenue Growth (5Y CAGR)+7.10%
    FCF Growth (3Y CAGR)+22.20%
    FCF Growth (5Y CAGR)-4.14%
    Operating Income Growth (3Y CAGR)-76.68%

    Revenue and profit by year

    Dividends and Yields

    TAK pays out 18.78% of earnings as dividends.

    Dividend Per Share (Annual)$0.63
    Dividend Yield2.91%
    Dividend Growth (3Y CAGR)-3.21%
    Dividend Growth (5Y CAGR)-6.78%
    Payout Ratio18.78%
    FCF Payout Ratio69.86%
    FCF Yield4.07%

    Full dividend history

    Peer Position

    Against 12 similar companies, TAK has the 9th highest P/S and the highest dividend yield.

    P/S Ratio2.3x vs 3.2x median
    ROIC5.58% vs 5.03% median
    Revenue Growth (Trailing 4 Quarters, YoY)+7.20% vs +5.10% median
    Dividend Yield2.91% vs 0.00% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About TAK

    What is TAK's market cap?

    Takeda Pharmaceutical Co Ltd ADR has a market cap of $68.98B.

    How many shares of TAK are outstanding?

    Takeda Pharmaceutical Co Ltd ADR has 3.21B shares outstanding. The count is up 1.73% from a year earlier.

    Does TAK pay a dividend?

    Yes. Takeda Pharmaceutical Co Ltd ADR pays $0.63 a share a year, a dividend yield of 2.91%.